Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IDERA PHARMACEUTICALS, INC.

(IDRA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Idera: Q2 Earnings Snapshot

08/09/2021 | 04:37pm EDT

EXTON, Pa. (AP) _ Idera Pharmaceuticals Inc. (IDRA) on Monday reported a loss of $7.6 million in its second quarter.

On a per-share basis, the Exton, Pennsylvania-based company said it had a loss of 15 cents.

In the final minutes of trading on Monday, the company's shares hit $1.07. A year ago, they were trading at $2.09.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDRA at https://www.zacks.com/ap/IDRA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about IDERA PHARMACEUTICALS, INC.
08/09IDERA : Q2 Earnings Snapshot
AQ
08/09IDERA PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Provides Corpora..
AQ
08/09IDERA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
08/09IDERA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Sta..
AQ
08/09Idera Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June ..
CI
06/25IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) added to Russell 3000E Value Index
CI
06/25IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) dropped from Russell Microcap Growth Index
CI
06/25IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) added to Russell Microcap Value Index
CI
06/25IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) dropped from Russell 3000E Growth Index
CI
06/22IDERA PHARMACEUTICALS : Thinking about buying stock in Biocept, Histogen, Idera Pharmaceut..
PR
More news
Analyst Recommendations on IDERA PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 89,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 0,48x
Yield 2021 -
Capitalization 47,1 M 47,1 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 32
Free-Float 78,3%
Chart IDERA PHARMACEUTICALS, INC.
Duration : Period :
Idera Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDERA PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 0,89 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Vincent J. Milano President, Chief Executive Officer & Director
John J. Kirby Chief Financial Officer & Senior Vice President
James Arthur Geraghty Chairman
Daniel B. Soland Chief Operating Officer & Senior Vice President
Mark Alan Goldberg Independent Director
Sector and Competitors
1st jan.Capi. (M$)
IDERA PHARMACEUTICALS, INC.-75.68%47
MODERNA, INC.219.34%135 157
LONZA GROUP AG27.29%58 232
IQVIA HOLDINGS INC.38.99%47 608
SEAGEN INC.-0.54%31 287
CELLTRION, INC.-39.28%24 952